Deborah Doroshow, ESMO 2020 – COVID-19 and Cancer Outcomes Study (CCOS): Disparities in Cancer during the COVID-19 Pandemic
Access all of the content
touchONCOLOGY joins Dr Deborah Doroshow to discuss the recent COVID-19 and Cancer Outcomes Study (CCOS), and how the COVID-19 pandemic has caused disparities in cancer care. Dr Doroshow presented her late-breaking abstract, ‘Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS)‘ (LBA74) at the Virtual 2020 ESMO Congress, 19–21 September 2020.
Questions
- What were the biggest challenges faced by cancer care providers during the COVID-19 pandemic? (0:14)
- What factors predispose cancer patients to increased risk for COVID-19-related morbidity and mortality? (1:12)
- Could you tell us about the aims and design of the CCOS study? (2:23)
- What were the major findings of the study? (5:01)
- What are the reasons for these disparities and what can be done to mitigate the effects of COVID-19? (6:02)
- Is there anything you would like to highlight in relation to the CCOS study? (7:22)
Speaker Disclosure: Deborah Doroshow has nothing to disclose in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the Virtual 2020 ESMO Congress.
